Segmentation - U.S. Sucralfate Market

U.S. Sucralfate Market, By Formulation (Tablet and Liquid Suspension), By Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Others Indications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By State (Illinois, Texas, New York, California, and Others)

掲載誌 : Feb 2026

Code : CMI2975

ページ :152

フォーマット :

Excel and PDF

産業 : Pharmaceutical

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

Market Dynamics

Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks.

Furthermore, monitoring of drugs including sucralfate in the U.S. by the government authorities for avoiding fatal conditions in the population is expected to drive the market growth. For instance, in 2017, the U.S. FDA updated name of 'Carafate suspension' to 'Carafate oral suspension' to avoid fatal complications with mistakenly intravenous administration of the drug.

Key features of the study

This report provides in-depth analysis of the U.S. sucralfate market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the U.S. sucralfate market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The U.S. sucralfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. sucralfate market

Market Segmentation